| Name | Title | Contact Details |
|---|
Powered by MRP wants to radically decrease healthcare cost with technology first solutions. Our commitment is to build the first digitally enabled end- to-end marketplace for Medical Aesthetic Professional. At Powered by MRP we focus on providing medical devices, resources, training, education and support to our customers to empower them to deliver top service to their clients. We are committed to a culture of collaboration where every voice is heard and understood. We believe in embracing diversity and that it brings better insight, solutions, and serves as the most intentional way to better our company. This supports our strategy, partnerships and collaboration to achieve being the most trusted Aesthetic Marketplace throughout the world.
American Medical Vision Technologies LLC is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Marus Dental International is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Key Medical Supply Inc is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. The Infrascanner enables clinicians to detect effectively, conveniently, and accurately intracranial bleeding in patients with head trauma. Intracranial hematomas are an important treatable cause of secondary brain injury in patients with head trauma. Recent statistics from Iraq shows that 30% of all wounded in action have head injuries; of them 40% have brain hematomas. Dr. Britton Chance (University of Pennsylvania) and Dr. Claudia Robertson (Baylor College of Medicine) invented a NIR system for detection of brain Hematomas and tested it successfully in 305 patients in Baylor. An entrepreneurial team formed a company around this technology in Collaboration with Drexel University and won the Wharton Business Plan competition in April 2004 and the second prize at the global business plan competition in Singapore in October 2004. Office of Naval Research funded the company in May 2004. The company also attracted $1.5M in funding from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, from Ben Franklin Technology Partners of Southeastern Pennsylvania, and from Philadelphia Industrial Development Corporation. A multicenter clinical study to support an FDA submission started in July 2006, and on February 2008 an application was submitted to the FDA. After 4 years of review, the FDA cleared Infrascanner Model 1000 as a DeNovo medical technology in December 2011. In January 2013 the FDA cleared the 510(k) of Infrascanner Model 2000.